Headache

Papers
(The H4-Index of Headache is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Erratum88
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin85
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample71
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma53
Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment49
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study47
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study42
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA38
A retrospective analysis of the use of candesartan for migraine prevention in adolescents37
Migraine screening in English and Spanish31
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space30
Migraine and peripheral pain models show differential alterations in neuronal complexity30
A retrospective cohort study of clinical factors, visit patterns, and demographic factors associated with use of remote communications in patients with headache29
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report29
Post‐traumatic headache: An unmet medical need28
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine27
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine26
Identifying cognitive‐affective mechanisms underlying disability in episodic migraine: Using the fear avoidance model to examine interactions26
A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine26
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes 25
Skin wetness sensitivity across body sites commonly affected by pain in people with migraine24
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine24
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers24
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity23
Clinical characteristics and perfusion‐computed tomography alterations in a series of patients with migraine with aura attended as stroke code23
Prevalence of primary stabbing headache: A meta‐analysis23
Sex and gender: Opportunities to expand research and understanding within headache medicine23
0.047904968261719